Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells

Gynecological Endocrinology

Volumn 24, Issue 5, 2008, Pages 250-256

  Park, Sung Hee ^a   Ramachandran, Sabarish ^a   Kwon, Sang Hoon ^a   Cha, Soon Do ^a   Seo, Eul Won ^b   Bae, Insoo ^c   Cho, Chiheum ^a   Song, Dae Kyu ^a  

^a Keimyung University   (South Korea)

^b Andong National University   (South Korea)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cell proliferation; Estrogen; KATP channel; Uterine leiomyoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ESTROGEN; GLIBENCLAMIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL;

ADULT; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; ENZYME ISOLATION; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOMA; MYOMETRIUM; PATCH CLAMP; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERUS MYOMA; WESTERN BLOTTING;

ADULT; CELL GROWTH PROCESSES; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FORMAZANS; GLYBURIDE; HUMANS; IMMUNOBLOTTING; KATP CHANNELS; LEIOMYOMA; MIDDLE AGED; PATCH-CLAMP TECHNIQUES; PINACIDIL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; UP-REGULATION; UTERINE NEOPLASMS;

EID: 45949089268     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590801893315     Document Type: Article

References (24)

1. Howe SR, Gottardis MM, Everitt JI, Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 1995;136: 4996-5003.
2. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004;10:207-220.
3. Van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs. Gynecol Endocrinol 2001; 15:61-68.
4. Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004;101:1455-1462.
5. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferators-activated receptor g ligands in uterine leiomyoma. Cancer Res 2003;63:1221-1227.
6. Bourlev V, Pavlovitch S, Stygar D, Volkov N, Lindblom B, Olovsson M. Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas. Gynecol Obstet Invest 2003; 55:199-204.
7. ATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 2004; 24:213-266.
8. ATP channels. Clin Exp Pharmacol Physiol 1994;21:583-597.
9. Harmon CS, Lutz D, Ducote J. Potassium channel openers stimulate DNA synthesis in mouse epidermal keratinocyte and whole hair follicle cultures. Skin Pharmacol 1993; 6:170-178.
10. Wondergem R, Cregan M, Strickler L, Miller R, Suttles J. Membrane potassium channels and human bladder tumor cells: II. Growth properties. J Membr Biol 1998;161: 257-262.
11. Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol 1995;162:163-171.
12. Deutch CE, Hasler JM, Houston RM, Sharma M, Stone VJ. Nonspecific inhibition of proline dehydrogenase synthesis in Escherichia coli during osmotic stress. Can J Microbiol 1989;35:779-785.
13. Jakimiuk AJ, Ogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wrobel A, Haczyriski J, Magoffin DA, Jakowicki JA. Estrogen receptor α and β expression in uterine leiomyomas from premenopausal women. Fertil Steril 2004;82:1244-1249.
14. + channels in pancreatic, cardiac, and vascular smoothmuscle cells. Am J Physiol Cell Physiol 1998;274:C25-C37.
15. Strobl JS, Wonderlin WF, Flynn DC. Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 1995;26:1643-1649.
16. 2+ influx in carcinoma cells of colon cancer. Life Sci 1999;65:55-62.
17. Malhi H, Irani AN, Rajvanshi P, Suadicani SO, Spray DC, McDonald TV, Gupta S. KATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting. J Biol Chem 2000;275: 26050-26057.
18. + channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int J Mol Med 2003; 11:261-266.
19. Nilius B, Wohlrab W. Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 1992;445: 537-548.
20. 2+ channel antagonists. Mol Chem Neuropathol 1994;22:81-95.
21. Wang YF, Jia H, Walker AM, Cukierman S. K-current mediation of prolactin-induced proliferation of malignant (Nb2) lymphocytes. J Cell Physiol 1992;152:185-189.
22. Chegini N, Ma C, Tang XM, Williams RS. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-β expression. Mol Hum Reprod 202;8:1071-1078.
23. Zaitseva M, Yue DS, Katzenellenbogen JA, Rogers PA, Gargett CE. Estrogen receptor-α agonists promote angiogenesis in human myometrial microvascular endothelial cells. J Soc Gynecol In vestig 2004;11:529-535.
24. West CP, Lumsden MA, Lawson S, Williamson J, Baird DT. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril 1987;48:45-51.